SCHEMBL8285192

SCHEMBL8285192

CNC(=O)c1c(F)cnc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.42
JAK2 O60674 2/20 0.40
JAK1 P23458 2/20 0.40
TYK2 P29597 2/20 0.40
PDE4D Q08499 2/20 0.40
GSK3B P49841 3/20 0.36
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND2 P30279 1/20 0.35
CCND3 P30281 1/20 0.35
PLK1 P53350 1/20 0.34
RIPK1 Q13546 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
CSF1R P07333 1/20 0.34
MAPK8 P45983 2/20 0.34
CDC7 O00311 1/20 0.34
AURKA O14965 1/20 0.34
ALK Q9UM73 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285209 0.91 PDE11A (0.43) PDE11APDE4DGSK3BCDK4CCND1
SCHEMBL8286065 0.87 PDE11A (0.46) PDE11AJAK2PDE4DGSK3BCDK4
SCHEMBL8285170 0.84 PDE11A (0.46) PDE11AJAK2TYK2PDE4DGSK3B
SCHEMBL8285162 0.81 PDE11A (0.43) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285168 0.79 PDE11A (0.42) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285222 0.79 PDE11A (0.41) PDE11APDE4DGSK3BCDK4CCND1
SCHEMBL8286060 0.78 PDE11A (0.46) PDE11AJAK2TYK2PDE4DGSK3B
SCHEMBL8287158 0.75 PDE11A (0.41) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287202 0.74 PDE11A (0.39) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5872390 0.73 PDE11A (0.45) PDE11AGSK3BCDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed